Drug Trial Radar · NCT01261494
Study With GFT505 (80mg) Versus Placebo in Patients With Type 2 Diabetes Mellitus
Last checked: Nov 19, 2026Latest source record: Jul 13, 2011 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
97
Actual
Start
Dec 2010
Primary completion
Jun 2011
Study completion Jun 2011
Sponsor
- Lead sponsor
- GenfitIndustry
- Sponsor type
- Industry
- First posted
- Dec 16, 2010
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is expected to demonstrate the anti-diabetic efficacy of 3-months treatment with GFT505 (80 mg/d) on Glycosylated Haemoglobin A1c (HbA1C) and fasting plasma glucose. And to assess the tolerability and safety of once-a-day administrations of oral doses of GFT505 for 12 weeks in patients with type 2 diabetes mellitus.
Conditions
- Type II Diabetes Mellitus
Interventions
GFT505 80mgDrug
hard gelatin capsules dosed at 20mg,oral administration,4 capsules per day before breakfast
PlaceboDrug
hard gelatin capsules,oral administration,4 capsules per day before breakfast
Primary outcomes
What the sponsor says the trial is designed to measure.
- HbA1cTime frame: 12 weeks
Locations
28 sites in 6 countries. Site status is shown where the registry gives one.
Site n°12
Banja Luka, Bosnia and Herzegovina
Site n°11
Sarajevo, Bosnia and Herzegovina
Site n°22
Riga, Latvia
Site n°21
Riga, Latvia
Site n°23
Valmiera, Latvia
Site n°41
Bălţi, Moldova
Site n°42
Chisinau, Moldova
Site n°43
Chisinau, Moldova
Site n°33
Bitola, North Macedonia
Site n°31
Skopje, North Macedonia
Site n°32
Skopje, North Macedonia
Site n°67
Bucharest, Romania
Site n°69
Bucharest, Romania
Site n°68
Bucharest, Romania
Site n°72
Oradea, Bihor County, Romania
Site n°66
Buzău, Buzău, Romania
Site n°64
Cluj-Napoca, Cluj, Romania
Site n°65
Baia Mare, Maramureş, Romania
Site n°63
Târgu Mureş, Mureș County, Romania
Site n°62
Târgu Mureş, Mureș County, Romania
Site n°71
Ploieşti, Prahova, Romania
Site n°70
Ploieşti, Prahova, Romania
Site n°61
Sibiu, Sibiu County, Romania
Site n°52
Belgrade, Serbia
Site n°53
Belgrade, Serbia
Site n°56
Belgrade, Serbia
Site n°54
Kragujevac, Serbia
Site n°51
Niš, Serbia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.